The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Mamyzin 269.5 mg/ml Powder and Solvent for Suspension for Injection for cattle

Boehringer Ingelheim Vetmedica GmbHVPA10454/009/001

Main Information

Trade NameMamyzin 269.5 mg/ml Powder and Solvent for Suspension for Injection for cattle
Active SubstancesPenethamate hydriodide
Dosage FormPowder and solvent for suspension for injection
Licence HolderBoehringer Ingelheim Vetmedica GmbH
License Holder AddressBinger Strasse 173
55216 Ingelheim am Rhein
Licence NumberVPA10454/009/001

Group Information

ATC CodeQJ01CE90 penethamate hydriodide
Therapeutic ClassAntibacterial


License statusAuthorised
Licence Issued03/03/2000
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back